Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016)
Prothena Corp Public's (PRTA) quarterly Interest & Investment Income came in at $277000.0 in Q1 2016, up 965.38% year-on-year from $26000.0 in Q2 2015, and up 246.25% quarter-over-quarter from $80000.0 in Q4 2015.
Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016) Analysis & Trends
Prothena Corp Public's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $277000.0 for Q1 2016.
- On a quarterly basis, Interest & Investment Income rose 965.38% year-over-year to $277000.0 in Q1 2016; TTM through Mar 2016 was $447000.0, a 419.77% increase from a year earlier, with the FY2015 full-year figure at $196000.0, up 148.1% from the prior year.
- Interest & Investment Income climbed to $277000.0 in Q1 2016 per PRTA's latest filing, from $80000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $277000.0 in Q1 2016 and bottomed at $5000.0 in Q4 2012.
- The 5-year median for Interest & Investment Income is $21500.0 (2013), against an average of $44857.1.
- Across the five-year window, Interest & Investment Income retreated 13.64% in 2014 and soared 965.38% in 2016, its largest moves.
- Year by year, Interest & Investment Income stood at $5000.0 in 2012, then jumped by 320.0% to $21000.0 in 2013, then climbed by 19.05% to $25000.0 in 2014, then surged by 220.0% to $80000.0 in 2015, then surged by 246.25% to $277000.0 in 2016.
- Per Business Quant, the three latest PRTA Interest & Investment Income figures stand at $277000.0 (Q1 2016), $80000.0 (Q4 2015), and $50000.0 (Q3 2015).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Prothena Corp Public | 471.02 Mn | 141.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 277,000.00 |
| Dec 31, 2015 | 80,000.00 |
| Sep 30, 2015 | 50,000.00 |
| Jun 30, 2015 | 40,000.00 |
| Mar 31, 2015 | 26,000.00 |
| Dec 31, 2014 | 25,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 16,000.00 |
| Mar 31, 2014 | 19,000.00 |
| Dec 31, 2013 | 21,000.00 |
| Sep 30, 2013 | 14,000.00 |
| Jun 30, 2013 | 14,000.00 |
| Mar 31, 2013 | 22,000.00 |
| Dec 31, 2012 | 5,000.00 |